Boris Shore

Consumer Services

Process Industries

Health Technology

Profile

Boris Shore is currently the President of Northern Potash Co. He previously worked as the Executive Director-Research & Development at Immune Pharmaceuticals, Inc. Dr. Shore obtained his undergraduate degree from Moscow University in 1971.

Boris Shore active positions

Companies	Position	Start
NORTHERN POTASH CO.	President	-

All active positions of Boris Shore

Former positions of Boris Shore

Companies	Position	End
IMMUNE PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Boris Shore's experience

Training of Boris Shore

Moscow University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Boris Shore's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NORTHERN POTASH CO.	Process Industries

Private companies	1
Immune Pharmaceuticals, Inc. Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ.	Health Technology